Sermorelin peptide canada
sermorelin peptide canada is a synthetic analogue of growth hormone–releasing hormone (GHRH 1-29). This truncated sequence maintains selective binding to GHRH receptors for focused endocrine regulation research. By isolating the active fragment, Sermorelin supports studies involving anterior pituitary response and growth hormone pathway signaling.
Product Info
Molecular formula: C163H269N51O49
Molecular weight: 3357.9
Purity: 99%+
Sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met
Reconstitution and Storage
Most standard lyophilised research vials use 2mL of bacteriostatic water for preparation. However, always check the product page or vial label for specific instructions.
For best handling, slowly add the bacteriostatic water along the inside wall of the vial. Avoid adding it directly onto the powder. This approach helps reduce unnecessary agitation and supports product integrity during laboratory use.
Next, gently swirl or roll the vial until the lyophilised powder fully dissolves. Avoid aggressive shaking. Excessive agitation may affect product stability.
After preparation, store the vial in a refrigerator between 2–8°C for best stability. Meanwhile, keep unprepared lyophilised vials in a cool, dry environment. Protect them from direct sunlight, moisture, and excessive heat.
Finally, follow the storage and handling instructions provided with each product. Proper handling helps maintain product purity, consistency, and reliability throughout laboratory applications.
Sermorelin in Canada is supplied by Polar Peptides as a lyophilized powder in sealed 5 mg research vials, available singly or in 3-vial and 10-vial packs. Sermorelin is a truncated growth hormone releasing hormone analogue studied in endocrine signalling research.
About Sermorelin
Sermorelin reproduces the first 29 residues of growth hormone releasing hormone, a sequence that runs to 44 residues in full. Its molecular weight is 3357.9.
Truncation rather than modification is the approach here, and the choice of where to cut is the interesting part: the first 29 residues are described in the literature as retaining the receptor activity of the whole hormone, so everything beyond that point can be removed without losing the property under study.
That makes it a useful reference in minimal-sequence research, where the question is how much of a natural molecule is actually required. Comparing it against a terminally modified analogue of the same hormone separates truncation effects from stabilisation effects.
Key research areas
- Minimal active sequence research
- Growth hormone releasing hormone receptor assays
- Truncation versus modification comparative studies
- Endocrine signalling models in cell culture
- Native hormone fragment characterisation
Specifications
- Format: lyophilized powder in a sealed research vial
- Size available: 5mg
- Pack options: 1 vial, 3 vials, or 10 pack
- Molecular formula: C163H269N51O49
- Molecular weight: 3357.9
- Sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu
- Stated purity: 99%+
Related GHRH-family sequences
A terminally modified analogue of the same hormone is Tesamorelin, and an albumin-binding version is CJC-1295 with DAC. A further superfamily member stocked here is VIP.
Frequently asked questions
How much of the natural hormone does sermorelin reproduce?
The first 29 residues of a 44-residue sequence.
How is the 5 mg vial supplied?
On its own, in a 3-vial pack, or in a 10 pack.
Sermorelin is supplied strictly for research use only and is intended for qualified laboratory, analytical, or educational research applications.







